Pre-clinical development and assessment of viral vectors expressing a fusion antigen of P. falciparum LSA1 and LSAP2 for efficacy against liver-stage malaria
Despite promising progress in malaria vaccine development in recent years, an efficacious subunit vaccine against P. falciparum (Pf) remains to be licensed and deployed. Cell mediated protection from liver-stage malaria is reliant on a sufficient number of antigen specific T cells reaching the liver...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Society for Microbiology
2019
|